Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Exploring the Future of Finance with Hanwha Life CEO | Kim Dong Kwan - CEO of Hanwha Corp
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Kim Dong Kwan is the CEO of Hanwha Corp
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Navigating the Transition to a Low-Carbon Economy: Insights from BlackRock | Rachel Lord, CEO, BlackRock UK
00:10:00
Mr. Anandan M Discusses the Importance of Risk and Reward in Business Strategy | Mr. Anandan M , Chairman, Aptus Value Housing Finance India Ltd.
00:10:00
A venture capital fund focused on early-stage companies in the positive living space|Amanda Eilian,Founding Partner,Able Partners
00:10:00
Olivia Lum: President of Hyflux, leading water and environmental solutions company based in Singapore.
00:10:00
Early-stage venture fund and incubator that founds and funds transformative companies|Kevin Ryan,Founder and CEO,AlleyCorp
00:10:00
Millicom CEO Mauricio Ramos is interviewed by CNN en Español's Gabriela Frías, with the video receiving 2.9K views over three years.
00:10:00
Chris Cole: The Forces Destabilizing Markets
00:10:00
"Peter Brereton is the President and CEO of TECSYS Inc."
00:10:00
Glenn Milnes, CEO of IkeGPS Group Limited, discusses the company's ambition to establish itself as the industry standard for collecting, analyzing, and managing pole and overhead asset information for utility and communication sectors during the ASX Small
00:10:00
Go Metals: Advancing Battery Metals Projects in Canada
00:10:00
The Rise and Challenges of Allbirds in Public Markets | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
Investor Working Group brought together investors and venture capital companies|Gary Sheynkman,General Partner, Leyden Ventures